CY1117495T1 - Δισκια πολλαπλων δοσομοναδων και διαδικασια παρασκευης τους - Google Patents

Δισκια πολλαπλων δοσομοναδων και διαδικασια παρασκευης τους

Info

Publication number
CY1117495T1
CY1117495T1 CY20161100281T CY161100281T CY1117495T1 CY 1117495 T1 CY1117495 T1 CY 1117495T1 CY 20161100281 T CY20161100281 T CY 20161100281T CY 161100281 T CY161100281 T CY 161100281T CY 1117495 T1 CY1117495 T1 CY 1117495T1
Authority
CY
Cyprus
Prior art keywords
domonated
discs
preparation procedure
phase
tablet
Prior art date
Application number
CY20161100281T
Other languages
English (en)
Inventor
Frédéric Gerber
Burkhard Schluetermann
Original Assignee
Add Technologies Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Add Technologies Ltd. filed Critical Add Technologies Ltd.
Publication of CY1117495T1 publication Critical patent/CY1117495T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Abstract

Δισκίο που περιλαμβάνει εσωτερική φάση, αποτελούμενο από α) ένα πρώτο είδος σύμπηκτων (I), -τα οποία περιέχουν μία πρώτη δραστική ουσία και τα οποία φέρουν επικάλυψη ή/και αποδεσμεύουν τροποποιημένα τη δραστική ουσία ή β) ένα πρώτο είδος επενδεδυμένης πρώτης δραστικής ουσίας (II), σε ανάμειξη με γ) σφαιρικά σωματίδια (II), και εξωτερική φάση με ένα ή περισσότερα έκδοχα συστατικά που δεν ήταν σε κοκκώδη μορφή προ της δισκιοποίησης, επιλεγμένα από μέσα διάλυσης, λιπαντικά, μέσα ρύθμισης ροής, πληρωτικά και συνδετικά μέσα, όπου όμως το βάρος της εξωτερικής φάσης δεν θα υπερβαίνει το 25% του συνολικού βάρους του δισκίου.
CY20161100281T 2008-09-24 2016-04-06 Δισκια πολλαπλων δοσομοναδων και διαδικασια παρασκευης τους CY1117495T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008048729A DE102008048729A1 (de) 2008-09-24 2008-09-24 Multipartikuläre Tabletten und Verfahren zur deren Herstellung
EP09778566.1A EP2346493B1 (de) 2008-09-24 2009-09-16 Multipartikuläre tabletten und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
CY1117495T1 true CY1117495T1 (el) 2017-04-26

Family

ID=41376179

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100281T CY1117495T1 (el) 2008-09-24 2016-04-06 Δισκια πολλαπλων δοσομοναδων και διαδικασια παρασκευης τους

Country Status (8)

Country Link
US (1) US20110177165A1 (el)
EP (1) EP2346493B1 (el)
CY (1) CY1117495T1 (el)
DE (1) DE102008048729A1 (el)
DK (1) DK2346493T3 (el)
ES (1) ES2566507T3 (el)
PL (1) PL2346493T3 (el)
WO (1) WO2010034425A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365961B1 (es) * 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
JP6392355B2 (ja) 2013-09-13 2018-09-19 アール．ピー．シェーラー テクノロジーズ、エルエルシー ペレット包含錠剤
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
US4904477A (en) * 1987-07-08 1990-02-27 American Home Products Corporation Spray dried ibuprofen compositions
US5780055A (en) * 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
PT1126826E (pt) * 1998-11-02 2008-11-25 Elan Pharma Int Ltd Composição de metilfenidato de libertação modificada multiparticulada
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
EP1235558B1 (en) * 1999-12-09 2006-05-03 The Boots Company PLC Compressed tablet composition comprising a nsaid
DE10044299A1 (de) * 2000-09-07 2002-03-21 Roehm Gmbh Multipartikuläre Arzneiform und Verfahren zu ihrer Herstellung
MXPA02009478A (es) * 2001-01-31 2003-03-10 Roehm Gmbh Forma medicinal de multiples particulas que comrpende por lo menos dos formas de bolitas recubiertas de diferente manera.
DE10104880A1 (de) * 2001-01-31 2002-08-08 Roehm Gmbh Multipartikuläre Arzneiform, enthaltend mindestens zwei unterschiedlich überzogene Pelletformen
DE10214002A1 (de) * 2002-03-27 2003-10-09 Roehm Gmbh Pharmazeutische Formulierung für den Wirkstoff Budesonid
DK1590144T3 (en) 2002-12-10 2015-11-09 Nortec Dev Ass Process for preparing biologically active formulations
US9107804B2 (en) * 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
MXPA05010636A (es) * 2003-04-04 2005-12-12 Pharmacia Corp Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada.
DE102004059792A1 (de) * 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
ES2434416T3 (es) * 2005-08-10 2013-12-16 Add Advanced Drug Delivery Technologies, Ltd. Preparación oral con liberación controlada
AU2008311289A1 (en) * 2007-10-10 2009-04-16 Avantor Performance Materials, Inc. Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof

Also Published As

Publication number Publication date
US20110177165A1 (en) 2011-07-21
PL2346493T3 (pl) 2016-07-29
ES2566507T3 (es) 2016-04-13
DE102008048729A1 (de) 2010-03-25
EP2346493A1 (de) 2011-07-27
WO2010034425A1 (de) 2010-04-01
DK2346493T3 (en) 2016-04-11
EP2346493B1 (de) 2016-01-06

Similar Documents

Publication Publication Date Title
CY1117495T1 (el) Δισκια πολλαπλων δοσομοναδων και διαδικασια παρασκευης τους
CY1118914T1 (el) Ανθεκτικες σε θραυση μορφες δοσολογησης με επιβραδυντικη απελευθερωση
CY1119172T1 (el) ΑΝΤΙΣΩΜΑ ANTI-cMET
CY1119312T1 (el) Εγκεκλεισμενες ανθεκτικες εναντι παραβιασης μορφες δοσολογιας ελεγχομενης αποδεσμευσης
Gameiro et al. The influence of drugs and systemic factors on orthodontic tooth movement
BR112016028288A2 (pt) ?composto, composição farmacêutica, métodos para tratamento de um indivíduo com uma doença ou condição e para inibir a quinase, e, uso de um composto?
CL2016002148A1 (es) Derivados de fenilen-1,5-diamina 2,4-disustituidos y aplicaciones de los mismos, y composiciones farmacéuticas y composiciones farmacéuticamente aceptables preparadas a partir de los mismos.
CY1121465T1 (el) Μεθοδοι και συνθεσεις για τη θεραπεια της φλεγμονωδους νοσου του εντερου
UY31145A1 (es) Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene
FR2949062B1 (fr) Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
BR112012024019A2 (pt) forma de dosagem de liberação controlada, e, método para liberar uma droga
BR112012026233A2 (pt) Sistema de tratamento por radiação
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
EA201691194A1 (ru) Стимуляторы ргц
ECSP13012605A (es) Filtros de humo para dispositivos para fumar con masas porosas que tienen una carga de parti?cula de carbono y una caida de presion encapsulada
BR102014018011A8 (pt) composição, uso da mesma e produto alimentar
ATE507721T2 (de) Milbenzusammensetzung
BR112015003655A2 (pt) composto; uso de um composto; e composição farmacêutica
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
AR075982A1 (es) Terapia de combinacion de un anticuerpo afucosilado y una o mas de las citoquinas seleccionadas de gm- csf humano, m -csf humano y/o il-3 humano y composicion
TR201818825T4 (tr) Kardi̇yak hi̇pertrofi̇ni̇n tedavi̇si̇ne ve tanisina yöneli̇k lncrnalar
CY1115955T1 (el) Ενα στερεο φαρμακευτικο σκευασμα
BR112016007322A2 (pt) composições compreendendo materiais de perfume compatíveis com polímero de poliamina
UY31146A1 (es) Derivado de 17b-ciano-19-nor-androst-4-eno, su uso y medicamento que lo contiene
BRPI0814293A2 (pt) Composição resistente ao calor, alimentação animal e uso da composição.